OMS Energy Technologies Inc. Issues Post-IPO Operational Update Featuring Customer Growth, Expansion Initiatives and R&D and Saf

Posted 5 hours ago by Two Blokes

SINGAPORE, June 19, 2025 (GLOBE NEWSWIRE) -- OMS Energy Technologies Inc. (“OMS” or the “Company”) (Nasdaq: OM

Source: Two Blokes Trading

Dupixent\u00ae (dupilumab) Approved in the U.S. as the Only Targeted Medicine to Treat Patients with Bullous Pemphigoid (BP)

Posted 5 hours ago by Two Blokes

Approval based on pivotal results showing improvements in sustained disease remission and reductions in itch a

Source: Two Blokes Trading

Dupixent\u00ae (dupilumab) Approved in the U.S. as the Only Targeted Medicine to Treat Patients with Bullous Pemphigoid (BP)

Posted 5 hours ago by Two Blokes

Approval based on pivotal results showing improvements in sustained disease remission and reductions in itch a

Source: Two Blokes Trading

HIVE Digital Technologies Surpasses 11 EH/s Bitcoin Hashrate Milestone as 100 MW Phase 1 in Paraguay Completed Ahead of Schedule

Posted 5 hours ago by Two Blokes

This news release constitutes a "designated news release for the purposes of the Company's amended and restate

Source: Two Blokes Trading

HIVE Digital Technologies Surpasses 11 EH/s Bitcoin Hashrate Milestone as 100 MW Phase 1 in Paraguay Completed Ahead of Schedule

Posted 5 hours ago by Two Blokes

This news release constitutes a "designated news release for the purposes of the Company's amended and restate

Source: Two Blokes Trading

HIVE Digital Technologies Surpasses 11 EH/s Bitcoin Hashrate Milestone as 100 MW Phase 1 in Paraguay Completed Ahead of Schedule

Posted 5 hours ago by Two Blokes

This news release constitutes a "designated news release for the purposes of the Company's amended and restate

Source: Two Blokes Trading

NurExone Advances U.S. Growth Strategy with Acceptance into Prestigious ARMI HealthTech Hub Accelerator and Provides Corporate U

Posted 5 hours ago by Two Blokes

TORONTO and HAIFA, Israel, June 20, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF)

Source: Two Blokes Trading

NurExone Advances U.S. Growth Strategy with Acceptance into Prestigious ARMI HealthTech Hub Accelerator and Provides Corporate U

Posted 5 hours ago by Two Blokes

TORONTO and HAIFA, Israel, June 20, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF)

Source: Two Blokes Trading

NurExone Advances U.S. Growth Strategy with Acceptance into Prestigious ARMI HealthTech Hub Accelerator and Provides Corporate U

Posted 5 hours ago by Two Blokes

TORONTO and HAIFA, Israel, June 20, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF)

Source: Two Blokes Trading

Warren Buffett's "Secret" Portfolio Just Bought the World's Leading Share-Buyback Stock, as Well as "The Monthly Dividend Compan

Posted 5 hours ago by Two Blokes

The amount of data that investors have to keep track of on Wall Street can be borderline overwhelming at times

Source: Two Blokes Trading

Warren Buffett's "Secret" Portfolio Just Bought the World's Leading Share-Buyback Stock, as Well as "The Monthly Dividend Compan

Posted 5 hours ago by Two Blokes

The amount of data that investors have to keep track of on Wall Street can be borderline overwhelming at times

Source: Two Blokes Trading

Neurophotonics Research & Therapeutics Market 2025-2029: Global and Regional Analysis by Type and End User Featuring Carl Zeiss,

Posted 5 hours ago by Two Blokes

Dublin, June 20, 2025 (GLOBE NEWSWIRE) -- The "Neurophotonics Market 2025-2029" report has been added to Resea

Source: Two Blokes Trading